文献速递心律失常

超越复发:重新定义心房颤动负荷作为预后与治疗终点

Beyond recurrence: redefining atrial fibrillation burden as a prognostic and therapeutic endpoint.
PubMed 文献 · Heart · 2026-03-12

本文综述心房颤动负荷的概念及其预后与治疗终点价值。传统按发作时长分类和以30秒复发判定消融失败均有局限,房颤负荷指监测期内房颤时间百分比,可能更准确反映消融对症状影响并作为预后标志物,但定义尚缺标准化,可穿戴设备与人工智能有望提升连续监测。

要点

  • 房颤负荷指监测期内房颤时间百分比,比二元复发结局更反映消融疗效。
  • 传统发作时长分类不能准确代表实际房颤时间,消融后复发与临床结局相关性有限。
  • 房颤负荷定义尚未标准化,需共识;可穿戴设备与人工智能可增强连续监测。

核心结论

  • 房颤负荷比传统二元复发结局更准确反映消融对症状的影响,并可作为特定患者亚组的预后标志物。
  • 房颤负荷缺乏标准化定义,需达成共识以推动其作为预后与治疗终点的应用。

研究设计与样本

  • 本文为综述,总结房颤负荷的影响与预后价值相关现有知识。

主要发现

  • 传统按发作时长分类不能准确代表实际房颤时间。
  • 消融后任何持续超过30秒的房性心律失常复发被判为失败,但复发与相关临床结局相关性不佳。
  • 新兴证据提示房颤负荷更准确反映消融对症状的影响,并作为特定患者亚组的预后标志物。

关键数值与推荐

  • 房颤负荷一般指监测期内处于心律失常的总时间百分比。
  • 传统消融结局评价将任何持续超过30秒的房性心律失常复发视为失败。

临床怎么用

  • 临床评估消融疗效时可关注房颤负荷而非仅凭30秒复发判定失败。
  • 利用可穿戴设备与人工智能加强连续监测以量化房颤负荷。

局限性

  • 房颤负荷在文献中定义不一致,缺乏标准化定义。
  • 需就房颤负荷的使用达成共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atrial fibrillation (AF) has traditionally been classified by episode duration, whereas rhythm control outcomes-via antiarrhythmic drugs or catheter ablation (CA)-have typically been evaluated using a binary approach, with any arrhythmic recurrence lasting over 30 s deemed a failure. Both definitions have notable limitations. Clinical classification often fails to accurately represent the actual time spent in arrhythmia, and AF recurrence following CA does not always correlate well with relevant clinical outcomes. This has driven increasing interest in the concept of AF burden which, although not consistently defined in literature, generally refers to the total percentage of time spent in arrhythmia during the monitoring period. Emerging evidence suggests that AF burden more accurately reflects the impact of CA on symptoms and serves as a valuable prognostic marker, particularly in specific patient subgroups.This review aims to summarise current knowledge on the impact and prognostic value of AF burden, highlighting unsolved issues, such as the absence of a standardised definition and the need for consensus on its use. Additionally, the review underscores the significance of monitoring strategies, highlighting the potential role that wearable devices and artificial intelligence could play in enhancing continuous monitoring in the near future.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ballatore A, Griffith Brookles C, O'Neill M, et al. Beyond recurrence: redefining atrial fibrillation burden as a prognostic and therapeutic endpoint. Heart. 2026. PMID: 41057250. doi:10.1136/heartjnl-2025-325779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。